These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Two rare deletions upstream of the NRXN1 gene (2p16.3) affecting the non-coding mRNA AK127244 segregate with diverse psychopathological phenotypes in a family. Duong LT; Hoeffding LK; Petersen KB; Knudsen CD; Thygesen JH; Klitten LL; Tommerup N; Ingason A; Werge T Eur J Med Genet; 2015 Dec; 58(12):650-3. PubMed ID: 26563496 [TBL] [Abstract][Full Text] [Related]
8. Fraternal twins with autism, severe cognitive deficit, and epilepsy: diagnostic role of chromosomal microarray analysis. Imitola J; Walleigh D; Anderson CE; Jethva R; Carvalho KS; Legido A; Khurana DS Semin Pediatr Neurol; 2014 Jun; 21(2):167-71. PubMed ID: 25149956 [TBL] [Abstract][Full Text] [Related]
9. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia. Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560 [TBL] [Abstract][Full Text] [Related]
10. Homozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings. Aksu Uzunhan T; Ayaz A Clin Neurol Neurosurg; 2022 Mar; 214():107141. PubMed ID: 35101781 [TBL] [Abstract][Full Text] [Related]
11. NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families. Al Shehhi M; Forman EB; Fitzgerald JE; McInerney V; Krawczyk J; Shen S; Betts DR; Ardle LM; Gorman KM; King MD; Green A; Gallagher L; Lynch SA Eur J Med Genet; 2019 Mar; 62(3):204-209. PubMed ID: 30031152 [TBL] [Abstract][Full Text] [Related]
12. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1. Gregor A; Albrecht B; Bader I; Bijlsma EK; Ekici AB; Engels H; Hackmann K; Horn D; Hoyer J; Klapecki J; Kohlhase J; Maystadt I; Nagl S; Prott E; Tinschert S; Ullmann R; Wohlleber E; Woods G; Reis A; Rauch A; Zweier C BMC Med Genet; 2011 Aug; 12():106. PubMed ID: 21827697 [TBL] [Abstract][Full Text] [Related]
13. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature. Béna F; Bruno DL; Eriksson M; van Ravenswaaij-Arts C; Stark Z; Dijkhuizen T; Gerkes E; Gimelli S; Ganesamoorthy D; Thuresson AC; Labalme A; Till M; Bilan F; Pasquier L; Kitzis A; Dubourgm C; Rossi M; Bottani A; Gagnebin M; Sanlaville D; Gilbert-Dussardier B; Guipponi M; van Haeringen A; Kriek M; Ruivenkamp C; Antonarakis SE; Anderlid BM; Slater HR; Schoumans J Am J Med Genet B Neuropsychiatr Genet; 2013 Jun; 162B(4):388-403. PubMed ID: 23533028 [TBL] [Abstract][Full Text] [Related]
14. [Intragenic deletions of NRXN1: three new case reports and a review of the phenotype]. Galán-Sánchez F; Esteban-Cantó V; Blaya-Fernández P; Jadraque-Rodríguez R; Manchón-Trives I; Alcaraz-Más L Rev Neurol; 2015 Mar; 60(5):215-8. PubMed ID: 25710691 [TBL] [Abstract][Full Text] [Related]
15. Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders. Duong L; Klitten LL; Møller RS; Ingason A; Jakobsen KD; Skjødt C; Didriksen M; Hjalgrim H; Werge T; Tommerup N Am J Med Genet B Neuropsychiatr Genet; 2012 Apr; 159B(3):354-8. PubMed ID: 22337556 [TBL] [Abstract][Full Text] [Related]